The contribution of neuroimaging for the study of cognitive deficits in Parkinson's disease

Clinical EEG and Neuroscience

Volumn 41, Issue 2, 2010, Pages 76-81

  Monchi, Oury ^a,b   Martinu, Kristina ^a,b   Strafella, Antonio P ^c,d  

^a CENTRE DE RECHERCHE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cognitive deficits; Dopamine; Functional magnetic resonance imaging; Parkinson's disease; Positron emission tomography

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; LEVODOPA;

BRAIN CORTEX; COGNITIVE DEFECT; DISEASE COURSE; DOPAMINERGIC SYSTEM; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NEUROBIOLOGY; NEUROIMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; STRIATONIGRAL DEGENERATION;

EID: 77952995672     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005941004100206     Document Type: Review

References (61)

1. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain 1986; 109 (Pt 5): 845-883.
2. Taylor AE, Saint-Cyr JA. The neuropsychology of Parkinson's disease. Brain Cogn 1995; 28: 281-296.
3. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurology 1997; 244: 2-8.
4. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988; 111 (Pt 2): 299-321.
5. Morris RG, Downes JJ, Sahakian BJ, Evenden JL, Heald A, Robbins TW. Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 757-766.
6. Saint-Cyr JA, Taylor AE, Lang AE. Procedural learning and neostriatal dysfunction in man. Brain 1988; 111 (Pt 4): 941-959.
7. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114 (Pt 5): 2095-2122.
8. Grossman M, Crino P, Reivich M, Stern MB, Hurtig HI. Attention and sentence processing deficits in Parkinson's disease: the role of anterior cingulate cortex. Cereb Cortex 1992; 2: 513-525.
9. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 1992; 107: 394-404.
10. Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115 (Pt 6): 1727-1751.
11. Owen AM, Beksinska M, James M, Leigh PN, Summers BA, Marsden CD, et al. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 1993; 31: 627-644. (Pubitemid 23225380)
12. Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994; 57: 79-88. (Pubitemid 24030912)
13. Aarsland D, Karlsen K. Neuropsychiatric aspects of Parkinson's disease. Curr Psychiatry Rep 1999; 1: 61-68.
14. Brown RG, Marsden CD. 'Subcortical dementia': the neuropsychological evidence. Neuroscience 1988; 25: 363-387.
15. Graham JM, Sagar HJ. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord 1999; 14: 10-20.
16. Owen AM, Iddon JL, Hodges JR, Summers BA, Robbins TW. Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia 1997; 35: 519-532. (Pubitemid 27144004)
17. Rogers RD, Sahakian BJ, Hodges JR, Polkey CE, Kennard C, Robbins TW. Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease. Brain 1998; 121 (Pt 5): 815-842. (Pubitemid 28220891)
18. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106 (Pt 2): 257-270. (Pubitemid 13098511)
19. Huber SJ, Shuttleworth EC, Paulson GW, Bellchambers MJ, Clapp LE. Cortical vs subcortical dementia. Neuropsychological differences. Arch Neurology 1986; 43: 392-394.
20. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986; 36: 1179-1185.
21. Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K, Dagher A. Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 2004; 24: 702-710. (Pubitemid 38166496)
22. Monchi O, Petrides M, Mejia-Constain B, Strafella AP. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement Brain 2007; 130: 233-244.
23. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC. Abnormal basal ganglia outflow in Parkinson's disease identified with PET: implications for higher cortical functions. Brain 1998; 121 (Pt 5): 949-965. (Pubitemid 28220900)
24. Fransson P. Spontaneous low-frequency BOLD signal fluctuations: an fMRI investigation of the resting-state default mode of brain function hypothesis. Hum Brain Mapp 2005; 26: 15-29. (Pubitemid 41232552)
25. Argyelan M, Carbon M, Ghilardi MF, Feigin A, Mattis P, Tang C, et al. Dopaminergic suppression of brain deactivation responses during sequence learning. J Neurosci 2008; 28: 10687-10695.
26. van Eimeren T, Monchi O, Ballanger B, Strafella AP. Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. Arch Neurology 2009; 66: 877-883.
27. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-134. (Pubitemid 39362633)
28. Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K. Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 2006; 21: 2042-2051.
29. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64: 1404-1410. (Pubitemid 40570509)
30. Jubault T, Brambati SM, Degroot C, Kullmann B, Strafella AP, Lafontaine AL, et al. Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI. PLoS One 2009; 4: e8247.
31. Menke RA, Scholz J, Miller KL, Deoni S, Jbabdi S, Matthews PM, Zarei, M. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neurolmage 2009; 47: 435-441.
32. Rosvold HE. The frontal lobe system: cortical-subcortical interrelationships. Acta Neurobiol Exp (Wars) 1972; 32: 439-460.
33. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med 1988; 318: 876-1480 (Pubitemid 18090271)
34. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000; 38: 596-612. (Pubitemid 30109440)
35. Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001; 11: 1136-1143. (Pubitemid 33108240)
36. Leh SE, Petrides M, Strafella AP. The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology 2010; 35(1): 7045.
37. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks, DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurology 1992; 32: 151-161.
38. Jenkins IH, Fernandez W, Playford ED, Lees AJ, Frackowiak RS, Passingham RE, Brooks DJ. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurology 1992; 32: 749-757.
39. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366-375.
40. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain, 2002; 125: 584-594. (Pubitemid 34194413)
41. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TN, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurology 2002; 51: 156-164. (Pubitemid 34111437)
42. Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 1980; 30: 1326-1330.
43. Swagushi T. The role of D1-dopamine related receptors in working memory-guided movements mediated by frontal cortical areas. Parkinsonism Related Disorders 2001; 7: 9-19.
44. Cools R, Barker RA, Sahakian BJ, Robbins TW. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 2001; 124: 2503-2512. (Pubitemid 33134938)
45. Milner B. Effects of brain lesions on card sorting. Arch Neurology 1963; 9: 90-100.
46. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976; 12: 313-324.
47. Monchi O, Petrides M, Petre V, Worsley K, Dagher A. Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 2001; 21: 7733-7741. (Pubitemid 32904972)
48. Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, Brooks DJ. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements: a PET study. Brain 1997; 120 (Pt 6): 963-976.
49. Mentis MJ, Dhawan V, Feigin A, Delalot D, Zgaljardic D, Edwards C, Eidelberg D. Early stage Parkinson's disease patients and normal volunteers: comparative mechanisms of sequence learning. Hum Brain Mapp 2003; 20: 246-258.
50. Nandhagopal R, McKeown MJ, Stoessl AJ. Functional imaging in Parkinson disease. Neurology 2008; 70: 1478-1488.
51. Ko JH, Ptito A, Monchi O, Cho SS, Van Eimeren T, Pellecchia G, et al. Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study. Neurolmage 2009; 46: 516-521.
52. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neurolmage 2007; 34: 714-723.
53. Jubault T, Monetta L, Strafella AP, Lafontaine AL, Monchi O. L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network. PLoS One 2009; 4: e6154.
54. Francois-Brosseau FE, Martinu K, Strafella AP, Petrides M, Simard F, Monchi O. Basal ganglia and frontal involvement in self-generated and externally-triggered finger movements in the dominant and non-dominant hand. Eur J Neurosci 2009; 29: 1277-1286.
55. Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA. Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci 2007; 27: 4832-4838.
56. Williams-Gray CH, Hampshire A, Barker RA, Owen AM. Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain 2008; 131:P 397-408.
57. Fossella J, Sommer T, Fan J, Wu Y, Swanson JM, Pfaff DW, Posner MI. Assessing the molecular genetics of attention networks. BMC Neurosci 2002; 3: 14.
58. Calabresi P, Galletti F, Saggese E, Ghiglieri V, Picconi B. Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. Parkinsonism Related Disorders 2007; 13: (suppl 3); S259-262.
59. Reinvang I, Lundervold AJ, Rootwelt H, Wehling E, Espeseth T. Individual variation in a cholinergic receptor gene modulates attention. Neurosci Lett 2009; 453: 131-134.
60. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci USA 2001; 98: 676-1482
61. Nagano-Saito A, Liu J, Doyon J, Dagher A. Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task. Neurosci Lett 2009; 458: 1-5.